Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lucid Diagnostics (LUCD) Cash from Investing Activities (2021 - 2025)

Lucid Diagnostics (LUCD) has disclosed Cash from Investing Activities for 5 consecutive years, with -$28000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Cash from Investing Activities rose 92.0% year-over-year to -$28000.0, compared with a TTM value of -$405000.0 through Sep 2025, up 27.94%, and an annual FY2024 reading of -$646000.0, down 192.31% over the prior year.
  • Cash from Investing Activities was -$28000.0 for Q3 2025 at Lucid Diagnostics, down from -$25000.0 in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at -$1000.0 in Q2 2021 and bottomed at -$2.4 million in Q2 2022.
  • Average Cash from Investing Activities over 5 years is -$332388.9, with a median of -$65000.0 recorded in 2024.
  • The sharpest move saw Cash from Investing Activities crashed 243500.0% in 2022, then surged 99.38% in 2023.
  • Year by year, Cash from Investing Activities stood at -$824000.0 in 2021, then soared by 75.36% to -$203000.0 in 2022, then increased by 13.79% to -$175000.0 in 2023, then plummeted by 48.0% to -$259000.0 in 2024, then skyrocketed by 89.19% to -$28000.0 in 2025.
  • Business Quant data shows Cash from Investing Activities for LUCD at -$28000.0 in Q3 2025, -$25000.0 in Q2 2025, and -$93000.0 in Q1 2025.